Related Experiment Video

Updated: Sep 19, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Interferons in oncology

P J Woll1, R Pettengell

  • 1Department of Clinical Oncology, University of Nottingham.

The British Journal of Clinical Practice
|March 1, 1997
PubMed

Insights

Interferons, glycoproteins with antiviral effects, are established treatments for certain leukemias and myeloma. Their use in solid tumors like lung and colorectal cancer remains experimental, with ongoing research into multi-modality treatment applications.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Interferons are natural glycoproteins with antiviral, antiproliferative, and immunomodulatory properties.
  • Recombinant human interferons are utilized in treating various malignancies.
  • Established efficacy in hairy cell leukemia, chronic myelogenous leukemia, and multiple myeloma.

Purpose of the Study:

  • To summarize the clinical applications of interferons in oncology.
  • To evaluate the role of interferons in multi-modality cancer treatment.
  • To review randomized studies on interferon efficacy in malignancies.

Main Methods:

  • Review of randomized clinical trials and practice applications.
  • Focus on oncological uses, excluding antiviral and immunomodulatory roles in non-cancer diseases.
  • Synthesis of evidence for interferon's place in cancer therapy.

Main Results:

  • Interferons are well-established for hematologic malignancies like leukemia and myeloma.
  • Documented activity in lymphoma, melanoma, renal cell cancer, and carcinoid tumors, though role is less clear.
  • Use in common solid tumors (lung, colorectal cancer) is still experimental.

Conclusions:

  • Interferons have a defined role in specific hematologic cancers.
  • Further research is needed to clarify their utility in solid tumors and as part of multi-modality treatment regimens.
  • The application of interferons in oncology is evolving, with ongoing investigation into their therapeutic potential.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...